Description: LabGenius Therapeutics is pioneering a closed-loop platform that combines AI, robotic automation, and synthetic biology to accelerate the discovery of next-generation therapeutic antibodies for solid tumours.
LabGenius raises \u00A335M Series B
LabGenius raises £35M Series B — Click to read more —
LabGenius raises £35M Series B — Click to read more — LabGenius raises £35M Series B — Click to read more —